| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Pres., Novocure Oncology | President, Cns Cancers Us | Chief Development Officer
1 company
Leonard Frank X is an EVP, Pres., Novocure Oncology at NovoCure Ltd. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $5.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 | NVCR Novocure Ltd | Chief Development Officer | Sell | 744 | $70.10 | $52,154.40 | -0.7% | +13.2% | +6.5% | |
| Mar 4, 2022 | NVCR Novocure Ltd | Chief Development Officer | Sell | 1,485 | $72.97 | $108,359.03 | -0.7% | +22.4% | +12.5% | |
| Sep 2, 2021 | NVCR Novocure Ltd | Chief Development Officer | Sell | 540 | $138.23 | $74,645.28 | -0.6% | -35.1% | -44.0% | |
| Aug 3, 2021 | NVCR Novocure Ltd | Chief Development Officer | Sell | 1,041 | $149.39 | $155,519.55 | -0.6% | -27.6% | -51.2% | |
| Mar 8, 2021 | NVCR Novocure Ltd | Chief Development Officer | Sell | 765 | $130.81 | $100,066.59 | -0.8% | - | - | |
| Mar 4, 2021 | NVCR Novocure Ltd | Chief Development Officer | Sell | 567 | $137.55 | $77,993.12 | -0.6% | - | - | |
| Mar 2, 2021 | NVCR Novocure Ltd | Chief Development Officer | Sell | 430 | $152.05 | $65,382.79 | -0.5% | - | - |